The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -58.74%. However, over the last six months, the performance has been stronger by -66.41%. The price of PCVX decreased -16.13% over the last 30 days. And in the last five days, it has fallen by -11.61%.
Vaxcyte Inc (PCVX) current stock price is $30.01. During the last trading session, the stock soared, reaching $163.0 after opening at $30.01. The stock’s lowest point was $50.0 before it closed at $33.0.
In terms of market performance, Vaxcyte Inc had a somewhat inconsistent run in.
52-week price history of PCVX Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Vaxcyte Inc’s current trading price is -75.21% away from its 52-week high, while its distance from the 52-week low is 8.50%. The stock’s price range over this timeframe has been between $27.66 and $121.06. The shares of the Healthcare sector company recorded a trading volume of approximately 2.63 million for the day, which was comparatively higher than the average daily volume of 1.64 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Vaxcyte Inc (PCVX) has experienced a quarterly rise of 3.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.87B and boasts a workforce of 414 employees.
Expert Opinions: Analysts’ Ratings for Vaxcyte Inc
As of right now, 9 analysts are rating Vaxcyte Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.38, with a change in price of -44.36. Similarly, Vaxcyte Inc recorded 2,084,843 in trading volume during the last 100 days, posting a change of -59.65%.
PCVX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PCVX stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
PCVX Stock Stochastic Average
The raw stochastic average for Vaxcyte Inc over the last 50 days is presently at 9.99%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 10.48%. Further, the company’s Stochastic %K and %D values for the last 20 days were 15.71% and 20.17%, respectively.
